Students with surnames later in the alphabet are given lower grades. Teachers might get more irritable the further they get through the alphabet
Why are some people not just ignorant but willfully ignorant? It's one thing to be a dumbass — but some people seem to be actively choosing to be a dumbass. This behavioral science study, highlighted in Scientific American, is cleverly designed to get to the bottom of why. — Read the rest
Humankind's two closest primate relatives are often said to embody contrasting sides of our nature: peace-loving bonobos versus violence-prone chimpanzees.
Meta's Threads is now confirmed to be testing a new, minor, yet essential, real-time search result option to help users find news and timely information by filtering results by recency.
Study finds voters skeptical about fairness of elections. Many favor a strong, undemocratic leader
COPENHAGEN, Denmark (AP) — Voters in 19 countries, including in three of the world’s largest democracies, are widely skeptical about whether their political elections are free and fair, and many favor a strong, undemocratic leader, according to a study released Thursday. The report by the International Institute for Democracy and Electoral Assistance, or International IDEA, []
A new study has found that voters in 19 countries, including in three of the world’s largest democracies, are widely skeptical about whether their political elections are free and fair
By JAN M. OLSEN Associated Press COPENHAGEN, Denmark (AP) — A new study has found that voters in 19 countries, including in three of the world’s largest democracies, are widely skeptical about whether their political elections are free and fair. And many favor a strong, undemocratic leader. The report Thursday by the International Institute for
For many people of various religions, fasting is seen as a path for aiding in repentance, self-control, and other spiritual benefits.
In a new study, researchers found that most cancer drugs granted accelerated approval do not demonstrate such benefits within five years.
In a new study, researchers found that most cancer drugs granted accelerated approval do not demonstrate such benefits within five years.
The U.S. Food and Drug Administration’s accelerated approval program is meant to give patients early access to promising drugs. But how often do these drugs actually improve or extend patients’ lives? In a new study, researchers found that most cancer drugs granted accelerated approval do not demonstrate such benefits within five years. “Five years after []